2026 Gavin Ha: Biology and Biochemistry Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Biology and Biochemistry	61	11071	10202	4784	4286	152	48206

Overview

Gavin Ha is affiliated with the Fred Hutchinson Cancer Research Center in the United States. Their research contributions span multiple areas within biochemistry, genetics, molecular biology, and medicine, with particular emphasis on cancer genomics and diagnostics.

The main fields of study in which Gavin Ha is active include:

Biochemistry, Genetics and Molecular Biology
Medicine

Within these broader areas, their work focuses on several subfields:

Molecular Biology
Cancer Research
Pulmonary and Respiratory Medicine
Oncology
Pathology and Forensic Medicine

Their research topics include:

Cancer Genomics and Diagnostics
Prostate Cancer Treatment and Research
Genetic factors in colorectal cancer
Epigenetics and DNA Methylation
RNA modifications and cancer
Molecular Biology Techniques and Applications
Lung Cancer Treatments and Mutations

Gavin Ha has contributed to several scientific publications, with recent papers including:

The evolutionary history of 2,658 cancers, 2020, Nature
Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes, 2021, Cell
Genome-wide cell-free DNA mutational integration enables ultra-sensitive cancer monitoring, 2020, Nature Medicine
Combined TP53 and RB1 Loss Promotes Prostate Cancer Resistance to a Spectrum of Therapeutics and Confers Vulnerability to Replication Stress, 2020, Cell Reports
Prostate cancer reactivates developmental epigenomic programs during metastatic progression, 2020, Nature Genetics

Frequent co-authors collaborating with Gavin Ha include:

Peter S. Nelson
Bruce Montgomery
Viktor A. Adalsteinsson
Minjeong Ko
Gad Getz

Gavin Ha's work has been published in journals and venues where they have maintained frequent contributions, such as:

bioRxiv (Cold Spring Harbor Laboratory)
Cancer Research
Nature Communications
Clinical Cancer Research
npj Precision Oncology

Best Publications

The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups

Christina Curtis;Christina Curtis;Sohrab P Shah;Suet-Feung Chin;Gulisa Turashvili

6086
Citations
The Immune Landscape of Cancer

Vésteinn Thorsson;David L Gibbs;Scott D Brown;Denise Wolf

4501
Citations
Oncogenic Signaling Pathways in The Cancer Genome Atlas

Francisco Sanchez-Vega;Marco Mina;Joshua Armenia;Walid K. Chatila

3193
Citations
Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.

Katherine A. Hoadley;Christina Yau;Christina Yau;Toshinori Hinoue;Denise M. Wolf

2565
Citations
Comprehensive Characterization of Cancer Driver Genes and Mutations.

Matthew H Bailey;Collin Tokheim;Eduard Porta-Pardo;Sohini Sengupta

2512
Citations
The clonal and mutational evolution spectrum of primary triple-negative breast cancers

Sohrab P. Shah;Andrew Roth;Rodrigo Goya;Arusha Oloumi

2232
Citations
ARID1A mutations in endometriosis-associated ovarian carcinomas.

Kimberly C. Wiegand;Sohrab P. Shah;Osama M. Al-Agha;Yongjun Zhao

1877
Citations
Genomic and Functional Approaches to Understanding Cancer Aneuploidy

Alison M. Taylor;Alison M. Taylor;Juliann Shih;Gavin Ha;Gavin Ha;Galen F. Gao

1116
Citations
The evolutionary history of 2,658 cancers

Moritz Gerstung;Moritz Gerstung;Clemency Jolly;Ignaty Leshchiner;Stefan C Dentro;Stefan C Dentro;Stefan C Dentro

981
Citations
PyClone: statistical inference of clonal population structure in cancer

Andrew Roth;Jaswinder Khattra;Damian Yap;Adrian Wan

959
Citations
Patterns of somatic structural variation in human cancer genomes

Yilong Li;Nicola D Roberts;Jeremiah A Wala;Jeremiah A Wala;Ofer Shapira;Ofer Shapira

942
Citations
Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients.

André Kahles;Kjong-Van Lehmann;Nora C Toussaint;Matthias Hüser

907
Citations
Pathogenic Germline Variants in 10,389 Adult Cancers

Kuan-Lin Huang;R Jay Mashl;Yige Wu;Deborah I Ritter

848
Citations
Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors

Viktor A. Adalsteinsson;Viktor A. Adalsteinsson;Gavin Ha;Gavin Ha;Samuel S. Freeman;Samuel S. Freeman;Atish D. Choudhury

799
Citations
Genetic and transcriptional evolution alters cancer cell line drug response

Uri Ben-David;Benjamin Siranosian;Gavin Ha;Gavin Ha;Helen Tang

770
Citations
Patient-derived xenografts undergo mouse-specific tumor evolution.

Uri Ben-David;Gavin Ha;Gavin Ha;Yuen-Yi Tseng;Noah F Greenwald;Noah F Greenwald;Noah F Greenwald

696
Citations
Dynamics of genomic clones in breast cancer patient xenografts at single-cell resolution

Peter Eirew;Peter Eirew;Adi Steif;Adi Steif;Jaswinder Khattra;Jaswinder Khattra;Gavin Ha;Gavin Ha

684
Citations
Genomic Copy Number Dictates a Gene-Independent Cell Response to CRISPR/Cas9 Targeting

Andrew J Aguirre;Robin M Meyers;Barbara A. Weir;Francisca Vázquez

619
Citations
Defuse: An algorithm for gene fusion discovery in tumor rna-seq data

Andrew McPherson;Fereydoun Hormozdiari;Abdalnasser Zayed;Ryan Giuliany

603
Citations
Erratum: Comprehensive Characterization of Cancer Driver Genes and Mutations (ARTICLE (2018) 173(2) (371–385), (S009286741830237X), (10.1016/j.cell.2018.02.060))

Matthew H. Bailey;Collin Tokheim;Eduard Porta-Pardo;Sohini Sengupta

589
Citations